Vitamin D3 tolerogenic dendritic cells

tolDC · University Hospital, Antwerp

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vitamin D3 tolerogenic dendritic cells, covering 2026-01-05 to 2026-01-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis [Phase 2]